It was striking to observe that cells derived from cancers that show high mutational rates for KRas, such as colon (HCT 116), lung (A549) and pancreatic (MiaPaca2) cancers, have high levels of expression of S100A10 (Supplementary Figure S5). Here, KRAS is linked to cancer.